Disease | Symptoms and Signs |
---|---|
Anemia | Pallor, fatigue, weakness, dizziness, chest pain, weight loss, jaundice, tachypnea and tachycardia, heart murmur, heart failure |
Polycythemia | Irritability, cyanosis, jaundice, headache, itching, bleeding or easy bruising, dizziness, tinnitus, blurry vision, seizures, stroke |
Neutropenia | Fever, pharyngitis, oral and perianal ulcerations, severe gingivitis, frequent or uncommon infections, cellulitis, lymphadenopathy, bacteremia |
Thrombocytopenia | Petechiae, ecchymoses, GI hemorrhage, epistaxis, hematuria, heavy menstrual bleeding, excessive bleeding from minor cuts or surgery |
Coagulopathy | Bruising, hemarthrosis, internal bleeding after minor trauma |
Thrombosis | Pulmonary embolus, DVT, stroke, seizures |
Hemoglobin (g/dL) | Packed Cell Volume (%) | Mcv (fl) | MCH (pg) | |||||
---|---|---|---|---|---|---|---|---|
Age (Y) | Mean | Lower Limit | Mean | Lower Limit | Mean | Lower Limit | Mean | Lower Limit |
0.5–4 | 12.5 | 11.0 | 36 | 32 | 80 | 72 | 28 | 24 |
5–10 | 13.0 | 11.5 | 38 | 33 | 83 | 75 | 29 | 25 |
11–14♀ | 13.5 | 12.0 | 39 | 34 | 85 | 77 | 29 | 26 |
11–14♂ | 14.0 | 12.0 | 41 | 35 | 85 | 77 | 29 | 26 |
15–19♀ | 13.5 | 12.0 | 40 | 34 | 88 | 79 | 30 | 27 |
15–19♂ | 15.0 | 13.0 | 43 | 37 | 88 | 79 | 30 | 27 |
20–44♀ | 13.5 | 12.0 | 40 | 35 | 90 | 80 | 31 | 27 |
20–44♂ | 15.5 | 13.5 | 45 | 39 | 90 | 80 | 31 | 27 |
- History and physical exam: Determine if acute or chronic bleeding, detailed diet history (milk intake, iron supplementation [breastfed neonates], folate, vitamin B12), infection, drugs, chemicals (lead ingestion), FHx (G6PD, thalassemia, splenomegaly, autoimmune d/o, bleeding d/o, jaundice), other chronic medical conditions. Check vitals (HR, BP, RR) and plot growth parameters. Perform a CV exam (systolic ejection murmur, gallop, cardiomegaly). Check for hepatomegaly and splenomegaly and signs of hypothyroidism.
- Initial lab workup: Primary: CBC, reticulocyte, peripheral smear; Secondary (if hemolysis suspected): Bilirubin, LDH, haptoglobin, UA (urobilinogen).
eFigure 18-2
Differential diagnosis algorithm for normocytic, normochromic anemia.
*Normal reticulocyte values by age: 0-2 days, 3-7%; 3-4 days, 1-3%; 5 days and older, 0.5-1.5%. Normal absolute reticulocyte values by age: 0-2 days 0.140-0.220 × 106/μL, 3-4 days 0.040-0.110 × 106/μL, 5 days and older 0.020-0.080 × 106/μL. Furthermore, a reticulocyte hemoglobin (RET-He), which provides a measure of iron availability for hemoglobin synthesis over the previous 3-4 days, may be helpful in diagnosing iron-defi ciency anemia, or in assessing response to therapy. Normal values: < 2 yrs, 24.5-35.2 pg; 2+ yrs, 27.1-35.4 pg.
Condition | Serum Iron | Transferrin | Ferritin | Bone Marrow Iron | TIBC | Reticulocyte | RDW | Mentzer Index* |
---|---|---|---|---|---|---|---|---|
Iron deficiency | Low | High | Low | Absent | High | Low | High | <13 |
Thalassemia minor | Normal or high | Normal | Normal or high | Normal or high | Normal or high | Normal | Normal | >13 |
Anemia of chronic disease | Low | Low | Normal or high | Normal or high | Normal or high | Normal | Normal | N/A |
- Presentation: Usually asymptomatic (screen at 6 and 12 mo or found incidentally on CBC); may show pallor and fatigue; ↑ HR. Usually caused by increased cow’s milk intake → which can lead to developmental delay in severe cases.
- Pathogenesis: Nutritional (child with ↑ milk intake with poor iron content, malabsorption). In adolescents, rapid growth and poor dietary intake or blood loss.
- Diagnosis: Usually made by history alone with trial of iron supplement, suggested by microcytic anemia on RBC indices, iron studies (see table above).
- Treatment: Limit cow’s milk intake to 16 oz/d. Start elemental iron (3–4 mg/kg/day) with a small amount of orange juice; treat until Hb is normal and then continue for 1 mo to replete stores.
α-Thalassemia | β-Thalassemia Major (Cooley’s, Homozygous) | β-Thalassemia Minor (Heterozygous) | |
---|---|---|---|
Presentation | Varies: Asymptomatic to hydrops fetalis | Severe hemolytic anemia in infancy, hepatosplenomegaly | Mild microcytic anemia |
Pathogenesis | Deficiency in α-globin synthesis (severity depends on how many of the 4 genes are deleted) | Complete absence of β-globin synthesis (β0/β0); Major to partial reduction (β+/β+; Intermediate) | Reduced or abnormal β-globin synthesis (heterozygous) |
Peripheral smear | Microcytic anemia | Severe hypochromia and microcytosis, fragmented RBCs, nucleated RBCs, | Hypochromia and microcytosis, |
NBS or Hb electrophoresis findings | Hb Bart (γ4) Hb H (β4) | Hb A (α2β2) absent ↑ Hb F (α2γ2) | Increased Hb A2 (α2δ2) ± ↑ Hb F (α2γ2) |
Typical population | Southeast Asia | Europe, Middle East, India, and Africa | Europe, Middle East, India, and Africa |
Treatment | Folic acid or transfusion therapy | Transfusion; splenectomy if severe | None necessary |
- Presentation: Rare in developed countries secondary to fortified grains and juices; Beefy, red, tongue, oral lesions, angular stomatitis, nausea/vomiting, abdominal pain, diarrhea.
- Pathogenesis: Dietary deficiency (infants drinking goat’s milk) or malabsorption, ↑ increased requirement because of high cell turnover or abnormal metabolism (patients taking phenytoin, phenobarbital, methotrexate or trimethoprim-sulfamethoxazole).
- Diagnosis: ↓ Folate level (<2 ng/mL is diagnostic; 2–4 ng/mL is equivocal; >4 ng/mL is not deficient). Also check serum cobalamin level.
- Treatment: Daily folate until anemia and megaloblastosis are resolved.
- Presentation: Diarrhea and weight loss, neurologic symptoms (ataxia and paresthesias).
- Pathogenesis: Dietary (child of a breastfeeding mother who is strict vegetarian), children with previous small bowel surgery (eg, NEC, intestinal atresia), ↓ absorption in terminal ileum because of ↓ intrinsic factor (pernicious anemia (pregnancy, lactation, malignancy); very rare in children).
- Diagnosis: ↓ Vitamin B12 level; WBC and platelets are often low to low-normal.
- Treatment: Vitamin B12 IM or deep SubQ loading dose; then monthly maintenance.
- Transient Erythroblastopenia of Childhood (TEC)
- Presentation: Later in infancy (usually between age 18–26 mo [range 6 mo–10 yr])
- Pathogenesis: Unknown but likely results from prolonged viral bone marrow suppression
- Diagnosis: Dx of exclusion; low reticulocytes, normal hemoglobin F
- Treatment: Blood transfusion only in cases of hemodynamic compromise; most cases resolve in 2-4 wk.
- Presentation: Later in infancy (usually between age 18–26 mo [range 6 mo–10 yr])
- Autoimmune hemolytic anemias
- Presentation: Often severe anemia found in the context of another underlying disorder
- Pathogenesis: Varied causes including infection, drugs, lymphoid neoplasm, SLE. Either intravascular coating of RBC by IgM Ab followed by destruction via complement activation, OR extravascular destruction (eg, by macrophages in spleen/liver) of IgG Ab coated RBCs.
- Diagnosis: Positive direct Coombs test result; spherocytes on peripheral smear ↑ bilirubin, LDH
- Treatment: Depends on the underlying cause: supportive care, transfusion, corticosteroids, splenectomy, immunosuppression
- Presentation: Often severe anemia found in the context of another underlying disorder
- Hereditary spherocytosis
- Presentation: May present as neonatal jaundice; jaundice or dark urine during metabolic or immunologic stress; splenomegaly
- Pathogenesis: AD transmission; defect in spectrin protein
- Diagnosis: Spherocytes on peripheral smear
- Treatment: Folic acid supplementation, RBC transfusion, splenectomy (definitive tx; consider in severe dz)
- Presentation: May present as neonatal jaundice; jaundice or dark urine during metabolic or immunologic stress; splenomegaly
- Glucose-6-phosphate dehydrogenase (G6PD) deficiency
- Sickle cell disorders
- Description: AR inheritance; 8% of African Americans have sickle cell trait (heterozygous); variations cause different severity (SS severity > Sβ0 thalassemia > SC > Sβ+ thalassemia)
- Diagnosis: Often identified on NBS or with positive FHx; send hemoglobin electrophoresis.
- Presentation: Symptoms occur > 6 mo age; persistence of fetal Hb (>30%) have mild or no.
- Secondary manifestations: Gallstones, renal disease, pulmonary hypertension, avascular necrosis, infection, retinopathy (autosplenectomy, 90% by age 6 yr).
- Treatment: Prophylactic penicillin VK (start by age 3 mo), folic acid (start by age 1 yr); chronic therapies → simple or partial exchange transfusions of PRBC (goal HbS fraction <30% and goal Hb to no higher than 10 g/dL)), hydroxyurea; stem cell transplant may be an option for patients with a matched sibling.
Event | Signs and Symptoms | Acute Treatment |
---|---|---|
Pain crises | Extremity, abdominal pain | Hydration, narcotics, NSAIDs (ibuprofen or ketorolac) |
Dactylitis (hand–foot syndrome) | Painful swelling of the hands and feet (in fancy) | Hydration, narcotics |
Splenic sequestration crisis | Hypotension, anemia (caused by pooling of RBC in the spleen), splenomegaly | Transfusion (simple or exchange), oxygen, splenectomy in severe cases |
Acute chest crisis | Fever, tachypnea, hypoxia, infiltrate (CXR) | Hydration, oxygen, transfusion (simple or exchange), incentive spirometry, positive-pressure ventilation if severe |
Aplastic crisis | Severe anemia with low reticulocytes | transfusion |
Stroke | Focal neurologic deficits, altered mental status | Exchange transfusion; chronic transfusion therapy shown to prevent 80% of second strokes in pediatrics |